iimpawu zomhlaza wesibindi 2026: Iimpawu zamva nje kunye neendleko zoNyango - Izibhedlele ezikufutshane nam

iindaba

Iindaba

iimpawu zomhlaza wesibindi 2026: Iimpawu zamva nje kunye neendleko zoNyango - Izibhedlele ezikufutshane nam

Umxholo Ukuqonda imiqondiso yamva nje yoMhlaza wesibindi kwi-2026 yeMingcipheko kwaye ngubani ekufuneka ajongwe kwiiNkqubo zokuHlola uQinisekiso loKhetho loNyango lweSibindi olufumaneka ngo-2026…

UNyango lwePrimary Lung Cancer 2026: Izikhokelo ezitsha kunye noNyango lwamva nje

Umxholo Ukuqonda uMhlaza oPhambili weMiphunga kunye neMigangatho yokuHlola ka-2026 eHlaziyiweyo yoNyango lweZikhokelo zoNyango oluNgaluncinci lweSeli eNcinci kwiNtuthuko yoMhlaza wamaLunga kwiSeli encinci kuLawulo loMhlaza wamaLunga aSakhasayo...

Amayeza oNyango lwe-Lung Cancer 2026: I-KRAS Entsha & ne-HER2 Amachiza

Umxholo Ixesha elitsha loNyango oluChanekileyo kwiNgxaki yoMhlaza weLung kwi-HER2 eJoliswe kuNyango oluPhuhliswayo kwi-KRAS Inhibitor Treatments Evolution of EGFR Targeted Therapies of the Key L...

Lung Cancer Treatment Surgery 2026: New Neo-Adjuvant Breakthroughs

Umxholo Ukuzivelela koTyando loNyango loMhlaza weLung ngo-2026 Ukuphumelela kwi-Immunotherapy-Isekwe kwi-Neo-Adjuvant Regimens ekuJoliswe kuNyango lwe-Driver-Mutation Positive Patients.

Inqanaba eliBanzi loNyango lweSeli emiNci yoMhlaza weMiphunga ngo-2026: Iza-bren eNtsha kunye neTarlatamab

Umxholo Ukuzivelela kweNqanaba eliBanzi kwiSigaba esiNcinci soNyango loMhlaza wamaLunga weSeli ye-Iza-bren: I-Paradigm Shift kwi-Bispecific ADC Therapy Tarlatamab kunye nokuPhakamisa kwe-T-Cell Engagers uKhuseleko kunye nokunyamezela kwi...

UKhetho oluNcinci lweCell Lung Cancer 2026: I-ADC entsha kunye ne-Immunotherapy Breakthroughs

Umxholo Ukuqonda iMeko yangoku yeeNdlela eziNcinci zoNyango loMhlaza wamaLunga weSeli yokuQala: Imidibaniso ye-Immunotherapy Ukunyuka kwe-Antibody-Drug Conjugates (ADCs) ekuJoliswe kwi-DLL3:...

Ekhaya
Amatyala aqhelekileyo
Malunga Nathi
Qhagamshelana nathi

Nceda usishiyele umyalezo